Zimmer Biomet Holdings (ZBH) Cash & Current Investments (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Cash & Current Investments of $424.2 million for Q1 2026, down 69.36% year-over-year from $1.4 billion in Q1 2025, and down 28.33% quarter-over-quarter from $591.9 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Cash & Current Investments (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Cash & Current Investments history runs 18 years deep, the most recent figure standing at $424.2 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 69.36% year-over-year to $424.2 million; the TTM figure through Mar 2026 stood at $424.2 million (down 69.36% YoY), while the FY2025 annual figure was $591.9 million, up 12.64% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $424.2 million, down from $591.9 million in the prior quarter.
- The five-year high for Cash & Current Investments was $1.4 billion in Q1 2025, with the low at $292.1 million in Q3 2023.
- The 5-year median for Cash & Current Investments is $424.2 million (2026), against an average of $544.6 million.
- The sharpest annual moves came in 2025 and 2026: Cash & Current Investments surged 252.29% in 2025, then plunged 69.36% in 2026.
- Zimmer Biomet Holdings' Cash & Current Investments stood at $375.7 million in 2022, then advanced by 10.67% to $415.8 million in 2023, then increased by 26.38% to $525.5 million in 2024, then advanced by 12.64% to $591.9 million in 2025, then retreated by 28.33% to $424.2 million in 2026.
- Business Quant data shows ZBH's Cash & Current Investments at $424.2 million in Q1 2026, $591.9 million in Q4 2025, and $1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 410.00 Mn |
| Mar 31, 2026 | 424.20 Mn |
| Dec 31, 2025 | 591.90 Mn |
| Sep 30, 2025 | 1.29 Bn |
| Jun 30, 2025 | 556.90 Mn |
| Mar 31, 2025 | 1.38 Bn |
| Dec 31, 2024 | 525.50 Mn |
| Sep 30, 2024 | 569.00 Mn |
| Jun 30, 2024 | 420.10 Mn |
| Mar 31, 2024 | 393.00 Mn |
| Dec 31, 2023 | 415.80 Mn |
| Sep 30, 2023 | 292.10 Mn |
| Jun 30, 2023 | 319.80 Mn |
| Mar 31, 2023 | 330.20 Mn |
| Dec 31, 2022 | 375.70 Mn |
| Sep 30, 2022 | 545.40 Mn |
| Jun 30, 2022 | 386.40 Mn |
| Mar 31, 2022 | 435.80 Mn |
| Dec 31, 2021 | 378.10 Mn |
| Sep 30, 2021 | 919.60 Mn |